팝업레이어 알림

팝업레이어 알림이 없습니다.
TOP

IMGT opens new possibilities with focused ultrasound,
advancing beyond the limits of conventional care

IMGT opens new possibilities with focused ultrasound,
advancing beyond the limits of conventional care

0102

IMGTFEATURES

VIEW MORE

Expandable FUS Platform

We harness the thermal and mechanical effects
of focused ultrasound to explore new indications,
drug modalities, and our product portfolio.

Global Network

Our global collaborations with clinical centers, researchers,
and the Focused Ultrasound Foundation help bring research
through clinical development to commercialization.

FUS Expertise & Innovation

We develop innovative therapies and products
through expertise that spans focused ultrasound
device development and clinical application.

IMGTMILESTONES

Our Journey from Research to Global Clinical Trials

VIEW MORE
  1. 2010

    Foundation of IMGT

    Beginning of FUS Development

  2. 2022

    ISO 9001:2015 Certification

    Establishment of a Global QMS

  3. 2024

    IR52 Jang Young‑sil Award

    Recognition for R&D Excellence

  4. 2025

    FDA Breakthrough Device Designation (BDD)

    Acknowledgment of the Potential to Advance Treatment

  5. 2026

    Conducting Pivotal Trials in the U.S. and Korea

    Key Step toward Regulatory Approval

QUALITY

INNOVATION

FOUNDATION

TECHNOLOGY

DEVELOPMENT

PRODUCT

Our Focused Ultrasound Product Portfolio

TOP